Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Andrew Snyder currently holds 13,920 shares of MEDICAL TRANSCRIPTION BILLING, CORP (MTBC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Andrew Snyder has been a net seller of MTBC stock. They have purchased $31.6K and sold $1.7M worth of shares.
Stephen Andrew Snyder's most recent insider trade was on May 15, 2026, when they sold 30,790 shares at $25.25 per share.
Stephen Andrew Snyder serves as Executive at MEDICAL TRANSCRIPTION BILLING, CORP (MTBC). They have executed 78 insider transactions totaling $1.7M over their tenure at the company.
Stephen Andrew Snyder holds the position of Executive at MEDICAL TRANSCRIPTION BILLING, CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Stephen Andrew Snyder has shown a selling trading pattern, with $31.6K in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen Andrew Snyder was on May 15, 2026, when they sold $777.4K worth of CCLD shares. This transaction involved 30,790 shares at $25.25 per share.
Stephen Andrew Snyder currently owns 13,920 shares of MEDICAL TRANSCRIPTION BILLING, CORP (MTBC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Andrew Snyder's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Andrew Snyder has 78 Form 4 filings on record as an insider at MEDICAL TRANSCRIPTION BILLING, CORP.
Set alerts for Stephen Andrew Snyder and 40,000+ other insiders.